On Air Now

Current Show

Ground Zero with Clyde Lewis   11:00 PM - 12:00 AM

Call in to Ground Zero at 1-888-673-3700

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 550 AM Wausau, WI 99.9 FM Stevens Point, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
63° Feels Like: 63°
Wind: SSW 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Mostly Clear 52°

Tomorrow

Mostly Sunny 76°

Fri Night

Showers Late 59°

Alerts

Galapagos says GSK starting trials of its new drug

BRUSSELS (Reuters) - Belgian biotech company Galapagos said on Tuesday that its partner GlaxoSmithKline (GSK) planned to start Phase II studies into a drug candidate to treat two auto-immune disorders.

Galapagos said in a statement that GSK would launch the studies for compound GSK2586184 in systemic lupus erythematosus (SLE) and chronic plaque psoriasis.

Galapagos is eligible to receive 34 million euros in additional milestones plus up to double-digit percentage royalties on global sales. It is the second selective JAK1 molecule discovered by Galapagos to enter Phase 2 studies.

(Reporting by Philip Blenkinsop)

Comments